286 related articles for article (PubMed ID: 15983959)
1. Mild hyperphosphatemia and mortality in hemodialysis patients.
Rodriguez-Benot A; Martin-Malo A; Alvarez-Lara MA; Rodriguez M; Aljama P
Am J Kidney Dis; 2005 Jul; 46(1):68-77. PubMed ID: 15983959
[TBL] [Abstract][Full Text] [Related]
2. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.
Block GA; Hulbert-Shearon TE; Levin NW; Port FK
Am J Kidney Dis; 1998 Apr; 31(4):607-17. PubMed ID: 9531176
[TBL] [Abstract][Full Text] [Related]
3. The relationship between serum calcium and phosphate levels and cardiac valvular procedures in the hemodialysis population.
Rubel JR; Milford EL
Am J Kidney Dis; 2003 Feb; 41(2):411-21. PubMed ID: 12552504
[TBL] [Abstract][Full Text] [Related]
4. [Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].
Rufino JM; García C; Vega N; Macía M; Hernández D; Rodríguez A; Maceira B; Lorenzo V
Nefrologia; 2011; 31(2):174-84. PubMed ID: 21461011
[TBL] [Abstract][Full Text] [Related]
5. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
[TBL] [Abstract][Full Text] [Related]
6. Dialyzer membrane permeability and survival in hemodialysis patients.
Chauveau P; Nguyen H; Combe C; Chêne G; Azar R; Cano N; Canaud B; Fouque D; Laville M; Leverve X; Roth H; Aparicio M;
Am J Kidney Dis; 2005 Mar; 45(3):565-71. PubMed ID: 15754279
[TBL] [Abstract][Full Text] [Related]
7. Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial.
Wald R; Rabbat CG; Girard L; Garg AX; Tennankore K; Tyrwhitt J; Smyth A; Rathe-Skafel A; Gao P; Mazzetti A; Bosch J; Yan AT; Parfrey P; Manns BJ; Walsh M
Clin J Am Soc Nephrol; 2017 Jun; 12(6):965-973. PubMed ID: 28550080
[TBL] [Abstract][Full Text] [Related]
8. Skipped treatments, markers of nutritional nonadherence, and survival among incident hemodialysis patients.
Unruh ML; Evans IV; Fink NE; Powe NR; Meyer KB;
Am J Kidney Dis; 2005 Dec; 46(6):1107-16. PubMed ID: 16310577
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of different serum phosphate ranges in subjects on hemodialysis.
Bhargava R; Kalra PA; Hann M; Brenchley P; Hurst H; Hutchison AJ
BMC Nephrol; 2019 Feb; 20(1):37. PubMed ID: 30717691
[TBL] [Abstract][Full Text] [Related]
10. Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.
Lin YC; Lin YC; Hsu CY; Kao CC; Chang FC; Chen TW; Chen HH; Hsu CC; Wu MS;
PLoS One; 2015; 10(6):e0129737. PubMed ID: 26107510
[TBL] [Abstract][Full Text] [Related]
11. Interdialytic weight gain and survival in hemodialysis patients: effects of duration of ESRD and diabetes mellitus.
Kimmel PL; Varela MP; Peterson RA; Weihs KL; Simmens SJ; Alleyne S; Amarashinge A; Mishkin GJ; Cruz I; Veis JH
Kidney Int; 2000 Mar; 57(3):1141-51. PubMed ID: 10720966
[TBL] [Abstract][Full Text] [Related]
12. The association of lipid levels with mortality in patients on chronic peritoneal dialysis.
Habib AN; Baird BC; Leypoldt JK; Cheung AK; Goldfarb-Rumyantzev AS
Nephrol Dial Transplant; 2006 Oct; 21(10):2881-92. PubMed ID: 16735386
[TBL] [Abstract][Full Text] [Related]
13. Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: a cohort study.
Sakaguchi Y; Fujii N; Shoji T; Hayashi T; Rakugi H; Iseki K; Tsubakihara Y; Isaka Y;
PLoS One; 2014; 9(12):e116273. PubMed ID: 25545498
[TBL] [Abstract][Full Text] [Related]
14. Serum Magnesium and Mortality in Hemodialysis Patients in the United States: A Cohort Study.
Lacson E; Wang W; Ma L; Passlick-Deetjen J
Am J Kidney Dis; 2015 Dec; 66(6):1056-66. PubMed ID: 26190226
[TBL] [Abstract][Full Text] [Related]
15. Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis.
Rivara MB; Ravel V; Kalantar-Zadeh K; Streja E; Lau WL; Nissenson AR; Kestenbaum B; de Boer IH; Himmelfarb J; Mehrotra R
J Am Soc Nephrol; 2015 Jul; 26(7):1671-81. PubMed ID: 25613037
[TBL] [Abstract][Full Text] [Related]
16. Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials.
Patel L; Bernard LM; Elder GJ
Clin J Am Soc Nephrol; 2016 Feb; 11(2):232-44. PubMed ID: 26668024
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.
Gutiérrez OM; Mannstadt M; Isakova T; Rauh-Hain JA; Tamez H; Shah A; Smith K; Lee H; Thadhani R; Jüppner H; Wolf M
N Engl J Med; 2008 Aug; 359(6):584-92. PubMed ID: 18687639
[TBL] [Abstract][Full Text] [Related]
18. Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
Copland M; Komenda P; Weinhandl ED; McCullough PA; Morfin JA
Am J Kidney Dis; 2016 Nov; 68(5S1):S24-S32. PubMed ID: 27772640
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.
Guh JY; Chen HC; Chuang HY; Huang SC; Chien LC; Lai YH
Am J Kidney Dis; 2002 Jun; 39(6):1245-54. PubMed ID: 12046038
[TBL] [Abstract][Full Text] [Related]
20. Comparing Dialysis Modality and Cardiovascular Mortality in Patients on Hemodialysis and Peritoneal Dialysis.
Refaat H; Sany D; Mohab A; Ezzat H
Adv Perit Dial; 2016; 32():22-31. PubMed ID: 28988586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
